Home  

Enter a class name or drug name above to search the database.

Increased Cellular Death [PE]

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
0008-0100 Besponsa inotuzumab ozogamicin Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2017-08-18
0074-0561 Venclexta Venetoclax AbbVie Inc. TABLET, FILM COATED 2016-04-11
0074-0566 Venclexta Venetoclax AbbVie Inc. TABLET, FILM COATED 2016-04-11
0074-0576 Venclexta Venetoclax AbbVie Inc. TABLET, FILM COATED 2016-04-11
0074-0579 Venclexta Venetoclax AbbVie Inc. KIT 2016-04-11

 Physiological Effect (PE) Classification 

Loading full table content...